Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

ERYTHROCIN I.V.

AMDIPHARM LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ERYTHROCIN I.V. in Canada?

A shortage of ERYTHROCIN I.V. 1G is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 8, 2026), but it has not started yet.

Why is ERYTHROCIN I.V. not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will ERYTHROCIN I.V. be available again?

The manufacturer's estimated resolution date is April 30, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found
StatusAnticipated Shortage
Same-ingredient products on file6 products
Expected resolution~7 months remaining (estimate)
Affected strength1G
Last updated2026-09-08

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

ILOTYCIN GLUCEPTATE IV AMPOULE 646 1GM

ELI LILLY CANADA INC

1G · DIN 00015415

Same strengthSame dosage formSame routeNo current shortage

ERYTHROCIN IV

ABBOTT LABORATORIES, LIMITED

1G · DIN 00000183

Same strengthSame dosage formSame routeNo current shortage

Other Products

ILOSONE LIQUID 125MG/5ML

ELI LILLY CANADA INC

125MG · DIN 00015474

Different strengthDifferent dosage formDifferent routeNo current shortage

NOVO-RYTHRO STEARATE TAB 250MG

NOVOPHARM LIMITED

250MG · DIN 00391581

Different strengthDifferent dosage formDifferent routeNo current shortage

ERYTHROCIN FILMTAB 500MG

ABBOTT LABORATORIES, LIMITED

500MG · DIN 00266515

Different strengthDifferent dosage formDifferent routeNo current shortage

ILOSONE LIQUID 250MG/5ML

ELI LILLY CANADA INC

250MG · DIN 00210641

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

00682276

Strength

1G

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

ERYTHROMYCIN

See all ERYTHROMYCIN products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History